Optune Pax Approved in Japan for Unresectable Locally Advanced Pancreatic Cancer – Novocure
Novocure announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Pax for the treatment of adult patients diagnosed with unresectable locally advanced pancreatic cancer, concomitant… read more.
